CV Sciences, Inc. Announces Expansion with the Launch of CV™ Acute and New Immunity Product LineGlobeNewsWire • 07/29/20
Analysts Estimate CV Sciences, Inc. (CVSI) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 07/28/20
CV Sciences, Inc. (CVSI) CEO Joseph Dowling on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/08/20
Analysts Estimate CV Sciences, Inc. (CVSI) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 05/06/20
CV Sciences, Inc. (CVSI) Upgraded to Buy: What Does It Mean for the Stock?Zacks Investment Research • 03/19/20
CV Sciences, Inc. (CVSI) CEO Joseph Dowling on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 03/17/20
Earnings Preview: CV Sciences, Inc. (CVSI) Q4 Earnings Expected to DeclineZacks Investment Research • 03/03/20
Cannabis Focus Shifting From Expansion To Profitability With Debra Borchardt (Podcast)Seeking Alpha • 01/15/20
CV Sciences, Inc. (CVSI) CEO Joseph Dowling on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 11/06/19
3 Marijuana Stocks You Should Buy, According to This 124-Year-Old Wall Street FirmThe Motley Fool • 08/19/19